Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Assessing Artificial Intelligence Solution Effectiveness: The Role of Pragmatic Trials
5
Zitationen
3
Autoren
2024
Jahr
Abstract
The emergence of artificial intelligence (AI) and other digital solutions in health care has considerably altered the landscape of medical research and patient care. Rigorous evaluation in routine practice settings is fundamental to the ethical use of AI and consists of 3 stages of evaluations: technical performance, usability and acceptability, and health impact evaluation. Pragmatic trials often play a key role in the health impact evaluation. The current review introduces the concept of pragmatic trials, their role in AI evaluation, the challenges of conducting pragmatic trials, and strategies to mitigate the challenges. We also examined common designs used in pragmatic trials and highlighted examples of published or ongoing AI trials. As more health systems advance into learning health systems, where outcomes are continuously evaluated to refine processes and tools, pragmatic trials embedded into everyday practice, leveraging data and infrastructure from delivering health care, will be a critical part of the feedback cycle for learning and improvement.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.821 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.601 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.598 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.591 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.654 Zit.